Nautilus Biotechnology Correlations

NAUT Stock

USD 2.30 0.06 2.68%

The current 90-days correlation between Nautilus Biotechnology and C4 Therapeutics is 0.3 (i.e., Weak diversification). The correlation of Nautilus Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Nautilus Biotechnology Correlation With Market

Very weak diversification

The correlation between Nautilus Biotechnology and DJI is 0.48 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.

Moving together with Nautilus Stock

0.67	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.62	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.84	IVVD	Invivyd	Pair Corr
0.64	PDSB	PDS Biotechnology Corp	Pair Corr
0.75	PEPG	PepGen	Pair Corr
0.77	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.72	BCYC	Bicycle Therapeutics	Pair Corr
0.75	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Nautilus Stock

0.64	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.6	NAMS	NewAmsterdam Pharma	Pair Corr
0.39	PMVP	Pmv Pharmaceuticals	Pair Corr
0.72	VREX	Varex Imaging Corp	Pair Corr
0.62	AGIO	Agios Pharm	Pair Corr
0.56	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.55	AVTE	Aerovate Therapeutics	Pair Corr
0.46	ANTX	AN2 Therapeutics	Pair Corr
0.41	CRVS	Corvus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	CCCC	KYMR	FHTX	RVMD	IPSC	BCAB	PMVP	CRBU	FIXX	DTIL
CCCC		0.59	0.41	-0.56	0.64	0.3	-0.07	0.16	0.1	0.72	CCCC
KYMR	0.59		0.53	-0.03	0.31	0.14	0.35	0.45	-0.08	0.14	KYMR
FHTX	0.41	0.53		-0.16	0.29	-0.13	-0.12	0.39	-0.22	0.33	FHTX
RVMD	-0.56	-0.03	-0.16		-0.68	0.16	0.66	0.57	-0.39	-0.83	RVMD
IPSC	0.64	0.31	0.29	-0.68		0.0	-0.38	-0.08	0.46	0.71	IPSC
BCAB	0.3	0.14	-0.13	0.16	0.0		0.33	0.3	-0.34	0.16	BCAB
PMVP	-0.07	0.35	-0.12	0.66	-0.38	0.33		0.65	-0.46	-0.48	PMVP
CRBU	0.16	0.45	0.39	0.57	-0.08	0.3	0.65		-0.55	-0.16	CRBU
FIXX	0.1	-0.08	-0.22	-0.39	0.46	-0.34	-0.46	-0.55		0.09	FIXX
DTIL	0.72	0.14	0.33	-0.83	0.71	0.16	-0.48	-0.16	0.09		DTIL
	CCCC	KYMR	FHTX	RVMD	IPSC	BCAB	PMVP	CRBU	FIXX	DTIL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DTIL	+ 0.72	CCCC
DTIL	+ 0.71	IPSC
PMVP	+ 0.66	RVMD
CRBU	+ 0.65	PMVP
IPSC	+ 0.64	CCCC
KYMR	+ 0.59	CCCC

High negative correlations

DTIL	- 0.83	RVMD
IPSC	- 0.68	RVMD
RVMD	- 0.56	CCCC
FIXX	- 0.55	CRBU
DTIL	- 0.48	PMVP
FIXX	- 0.46	PMVP

Risk-Adjusted Indicators

There is a big difference between Nautilus Stock performing well and Nautilus Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nautilus Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CCCC	3.62	(0.55)	0.00	(0.35)	0.00	0.00	8.59	(7.98)	23.66
KYMR	2.37	(0.26)	0.00	(0.01)	0.00	0.00	4.84	(4.74)	18.10
FHTX	3.94	(0.26)	0.00	0.03	4.42	(4.30)	8.50	(6.81)	34.64
RVMD	2.00	0.34	0.15	0.41	2.02	(2.17)	4.81	(3.24)	10.95
IPSC	3.97	(0.39)	0.00	(0.02)	0.00	0.00	7.44	(8.82)	21.67
BCAB	4.40	(0.15)	(0.02)	0.02	4.72	(5.62)	12.86	(7.59)	31.41
PMVP	1.55	(0.03)	(0.03)	0.07	1.99	(1.87)	3.75	(3.64)	13.98
CRBU	3.65	(0.20)	0.00	0.05	4.65	(4.03)	8.91	(6.63)	28.53
FIXX	2.82	0.04	0.01	0.16	3.52	(3.25)	5.77	(5.61)	19.43
DTIL	2.12	(0.51)	0.00	(0.62)	0.00	0.00	5.37	(5.25)	18.01

Nautilus Biotechnology Corporate Management

Gwen Weld	Chief Officer	Profile
Parag Mallick	Chief CoFounder	Profile
Sujal Patel	CEO, CoFounder	Profile
Mary Godwin	Senior Operations	Profile
Chris Blessington	Vice Communications	Profile
Subra Sankar	Senior Development	Profile
Kentaro Suzuki	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC